Germany
Japan
United Kingdom
China
ALK mouse monoclonal antibody, clone OTI1A4
| Applications | IHC, LMNX, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Antibodies
View as table Download
.jpg?d=110x100 "User supplied image")
Rabbit polyclonal DDR1 (Tyr513) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human DDR1 around the phosphorylation site of tyrosine 513 (P-A-YP-R-L). |
| Modifications | Phospho-specific |
Rabbit Polyclonal VLK Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | VLK antibody was raised against a 15 amino acid synthetic peptide from near the center of human VLK. The immunogen is located within amino acids 320 - 370 of VLK. |
Rabbit polyclonal Bi-Phospho-ERK1/2(T202/Y204) Antibody
| Applications | Dot, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This ERK1/2 Antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding T202/Y204 of human ERK1/2. |
| Modifications | Phospho-specific |
Rabbit anti-VEGFR (Phospho-Tyr951) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanVEGFR2 around the phosphorylation site of tyrosine 951 (K-D-YP-V-G). |
| Modifications | Phospho-specific |
Rabbit Polyclonal JNK1/2/3 (Thr183+Tyr185) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human JNK1/2/3 around the phosphorylation site of Threonine 183+Tyrosine 185 |
| Modifications | Phospho-specific |
Rabbit Polyclonal VEGFR2 (Tyr1214) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human VEGFR2 around the phosphorylation site of Tyrosine 1214 |
| Modifications | Phospho-specific |
Rabbit polyclonal FGFR4 (Tyr642) antibody(Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human FGFR4 around the phosphorylation site of tyrosine 642. |
| Modifications | Phospho-specific |
Rabbit Polyclonal SYK (Tyr348) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human SYK around the phosphorylation site of Tyrosine 348 |
| Modifications | Phospho-specific |
Rabbit Polyclonal Anti-MYLK Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-MYLK Antibody: A synthesized peptide derived from human MYLK |
Rabbit Polyclonal Anti-TGFR2 Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-TGFR2 Antibody: A synthesized peptide derived from human TGFR2 |
Rabbit polyclonal PKC zeta (Thr410) antibody(Phospho-specific)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human PKC? around the phosphorylation site of threonine 410 (T-S-TP-F-C). |
| Modifications | Phospho-specific |
Goat Anti-ERN1 / IRE1a Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-PNAHGKIKAMISD, from the internal region of the protein sequence according to NP_001424.3. |
Rabbit polyclonal anti-PLK3 antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized peptide derived from internal of human PLK3. |
Rabbit polyclonal JAK2 (Tyr570) antibody(Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human JAK2 around the phosphorylation site of tyrosine 750 (G-D-YP-G-Q). |
| Modifications | Phospho-specific |
Rabbit Polyclonal AurB (Thr232) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human AurB around the phosphorylation site of Threonine 232 |
| Modifications | Phospho-specific |
Rabbit Polyclonal LIMK1/2 (Thr508/505) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human LIMK1/2 around the phosphorylation site of Threonine 508/505 |
| Modifications | Phospho-specific |
Rabbit Polyclonal Trk B (Tyr515) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human Trk B around the phosphorylation site of Tyrosine 515 (peptide seq 509-521aa: VIENPQY(p)FGITN) |
| Modifications | Phospho-specific |
Rabbit Polyclonal ROCK1 Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human ROCK1 |
Mouse Anti-CDK5 Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit anti-MTOR polyclonal antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antibody was produced against synthesized non-phosphopeptide derived fromhuman mTOR around the phosphorylation site of serine 2448 (T-D-SP-Y-S). |
Rabbit Polyclonal JNK1/2/3 Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human JNK1/2/3 |
Carrier-free (BSA/glycerol-free) PAK4 mouse monoclonal antibody, clone OTI1C7 (formerly 1C7)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Anti-PAK7 Rabbit Polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein corresponding to C terminal 300 amino acids of human p21 protein (Cdc42/Rac)-activated kinase 7p21 protein (Cdc42/Rac)-activated kinase 7 |
Anti-CDK6 Rabbit Polyclonal Antibody
| Applications | ELISA, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein corresponding to a region derived from 13-300 amino acids of Human Cyclin-dependent kinase 6 |
Rabbit Polyclonal Anti-NPR2 Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide of human NPR2 |
Anti-JNK1 (JNK1) mouse monoclonal antibody, clone OTI2F10 (formerly 2F10)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Anti-JNK1 (JNK1) mouse monoclonal antibody, clone OTI2F10 (formerly 2F10)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Active filters
Category
- Antibodies
Reactivities
- Rat
Applications
- WB
Conjugates
- Unconjugated
Families
- Protein Kinase
Citations
- Yes
Filter by
Target Symbol
- MAPK8 (6)
- ALK (5)
- MAPK1 (4)
- ERBB2 (3)
- JAK2 (3)
- LIMK1 (3)
- MAPK3 (3)
- NTRK2 (3)
- TGFBR2 (3)
- AKT1 (2)
- AKT3 (2)
- BRAF (2)
- BTK (2)
- CDK2 (2)
- CDK5 (2)
- FGFR2 (2)
- FGFR3 (2)
- IGF1R (2)
- KDR (2)
- MAP2K1 (2)
- MAP3K5 (2)
- MET (2)
- NTRK1 (2)
- STK3 (2)
- STK38L (2)
- TYRO3 (2)
- AURKB (1)
- CDK6 (1)
- DDR1 (1)
- EGFR (1)
- ERN1 (1)
- FGFR4 (1)
- JAK1 (1)
- MAPK4 (1)
- MTOR (1)
- MYLK (1)
- NPR2 (1)
- PAK1 (1)
- PAK2 (1)
- PAK4 (1)
- PAK5 (1)
- PIK3R4 (1)
- PKDCC (1)
- PLK3 (1)
- PRKCZ (1)
- PTK2 (1)
- PTK2B (1)
- ROCK1 (1)
- SYK (1)
- TRPM7 (1)
Antibody Hosts
Isotypes
Clonalities
Knockout (KO) Validation
Modifications
Pathways
- Pathways in cancer (44)
- MAPK signaling pathway (41)
- Focal adhesion (38)
- ErbB signaling pathway (31)
- Pancreatic cancer (30)
- Colorectal cancer (29)
- Neurotrophin signaling pathway (28)
- Regulation of actin cytoskeleton (27)
- Prostate cancer (26)
- Progesterone-mediated oocyte maturation (25)
- Chemokine signaling pathway (23)
- Insulin signaling pathway (23)
- Fc epsilon RI signaling pathway (22)
- Melanoma (21)
- Renal cell carcinoma (21)
- Axon guidance (20)
- Glioma (20)
- Non-small cell lung cancer (20)
- Chronic myeloid leukemia (19)
- Endometrial cancer (19)
- Toll-like receptor signaling pathway (19)
- Adherens junction (18)
- Endocytosis (18)
- Fc gamma R-mediated phagocytosis (18)
- Bladder cancer (17)
- GnRH signaling pathway (17)
- T cell receptor signaling pathway (17)
- Acute myeloid leukemia (16)
- B cell receptor signaling pathway (16)
- VEGF signaling pathway (16)
- Type II diabetes mellitus (15)
- Adipocytokine signaling pathway (14)
- Natural killer cell mediated cytotoxicity (14)
- Vascular smooth muscle contraction (14)
- mTOR signaling pathway (14)
- Long-term depression (13)
- NOD-like receptor signaling pathway (13)
- Oocyte meiosis (13)
- Thyroid cancer (13)
- Long-term potentiation (11)
- TGF-beta signaling pathway (11)
- Alzheimer's disease (10)
- Dorso-ventral axis formation (10)
- Epithelial cell signaling in Helicobacter pylori infection (10)
- Gap junction (10)
- Melanogenesis (9)
- Prion diseases (9)
- Cytokine-cytokine receptor interaction (8)
- Jak-STAT signaling pathway (8)
- Small cell lung cancer (8)
- Wnt signaling pathway (7)
- Apoptosis (6)
- Calcium signaling pathway (6)
- RIG-I-like receptor signaling pathway (6)
- Tight junction (5)
- Cell cycle (3)
- Leukocyte transendothelial migration (3)
- p53 signaling pathway (3)
- Amyotrophic lateral sclerosis (ALS) (2)
- Primary immunodeficiency (2)
- Pathogenic Escherichia coli infection (1)
- Purine metabolism (1)
- Regulation of autophagy (1)